tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SYRE Stock Latest News

Spyre Therapeutics files $500M mixed securities shelf
The FlySpyre Therapeutics files $500M mixed securities shelf
13d ago
SYRE
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
PremiumThe Fly
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
16d ago
APGE
SYRE
Spyre Therapeutics initiated with an Outperform at Wedbush
PremiumThe Fly
Spyre Therapeutics initiated with an Outperform at Wedbush
16d ago
SYRE
Spyre Therapeutics management to meet with BTIG
PremiumThe Fly
Spyre Therapeutics management to meet with BTIG
1M ago
SYRE
Spyre Therapeutics reports Q2 EPS (86c), consensus (95c)
PremiumThe Fly
Spyre Therapeutics reports Q2 EPS (86c), consensus (95c)
1M ago
SYRE
Spyre Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress ReleasesSpyre Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
SYRE
Spyre Therapeutics management to meet virtually with BTIG
Premium
The Fly
Spyre Therapeutics management to meet virtually with BTIG
2M ago
SYRE
Spyre Therapeutics initiated with an Outperform at Evercore ISI
Premium
The Fly
Spyre Therapeutics initiated with an Outperform at Evercore ISI
2M ago
SYRE
Spyre Therapeutics doses first patients in Phase 1 trial of bowel disease drug
PremiumThe Fly
Spyre Therapeutics doses first patients in Phase 1 trial of bowel disease drug
3M ago
SYRE
Spyre Therapeutics Announces Updated Share Structure
PremiumCompany Announcements
Spyre Therapeutics Announces Updated Share Structure
4M ago
8K
SYRE
Spyre Therapeutics Expands Portfolio and Strengthens Leadership
PremiumCompany Announcements
Spyre Therapeutics Expands Portfolio and Strengthens Leadership
4M ago
8K
SYRE
Spyre Therapeutics price target raised to $40 from $32 at BTIG
PremiumThe Fly
Spyre Therapeutics price target raised to $40 from $32 at BTIG
4M ago
SYRE
Spyre Therapeutics reports Q1 EPS ($1.20), consensus ($1.17)
PremiumThe FlySpyre Therapeutics reports Q1 EPS ($1.20), consensus ($1.17)
4M ago
SYRE
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4M ago
SYRE
Carvana upgraded, Block downgraded: Wall Street’s top analyst calls
Premium
The Fly
Carvana upgraded, Block downgraded: Wall Street’s top analyst calls
5M ago
SQ
CVS
Spyre Therapeutics initiated with an Outperform at Baird
PremiumThe Fly
Spyre Therapeutics initiated with an Outperform at Baird
5M ago
SYRE
Spyre Therapeutics files to sell 33.36M shares of common stock for holders
PremiumThe Fly
Spyre Therapeutics files to sell 33.36M shares of common stock for holders
5M ago
SYRE
Spyre Therapeutics price target raised to $54 from $36 at Stifel
PremiumThe Fly
Spyre Therapeutics price target raised to $54 from $36 at Stifel
6M ago
APGE
ATXS
Spyre Therapeutics Secures $180M in Strategic Financial Move
PremiumCompany Announcements
Spyre Therapeutics Secures $180M in Strategic Financial Move
6M ago
8K
SYRE
Spyre Therapeutics announces $180M private placement
PremiumThe FlySpyre Therapeutics announces $180M private placement
6M ago
SYRE
Spyre Therapeutics price target raised to $50 from $44 at Guggenheim
Premium
The Fly
Spyre Therapeutics price target raised to $50 from $44 at Guggenheim
7M ago
SYRE
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
Premium
The Fly
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
7M ago
EL
PG

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >